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ABSTRACT
TheNS1 protein of influenza virus hasmultiple functions and is a determinant of virulence. Influenza viruseswithNS1 deletions
(DelNS1 influenza viruses) are a useful tool for studying virus replication and can serve as effective live attenuated vaccines, but dele-
tion ofNS1 severely diminishes virus replication, hampering functional studies and vaccine production.We found thatWSN-DelNS1
viruses passaged in cells consistently adapted to gain anA14U substitution in the 3=noncoding region of theM segment of viral RNA
(vRNA)which restored replicative ability. DelNS1-M-A14Uviruses cannot inhibit interferon expression in virus infected-cells, provid-
ing an essentialmodel for studying virus replication in the absence of theNS1 protein. Characterization ofDelNS1-M-A14Uvirus
showed that the lack ofNS1 has no apparent effect on expression of other viral proteins, with the exception ofMmRNAs. Expression of
theM transcripts,M1,M2,mRNA3, andmRNA4, is regulated by alternative splicing. TheA14U substitution changes the splicing do-
nor site consensus sequence ofmRNA3, altering expression ofM transcripts, withM2 expression significantly increased andmRNA3
markedly suppressed inDelNS1-M-A14U, but notDelNS1-M-WT, virus-infected cells. Further analysis revealed that theA14U substi-
tution also affects promoter function during replication of the viral genome. TheM-A14Umutation increasesMvRNA synthesis in
DelNS1 virus infection and enhances alternative splicing ofM2mRNA in the absence of other viral proteins. The findings demonstrate
thatNS1 is directly involved in influenza virus replication throughmodulation of alternative splicing ofM transcripts and provide
strategic information important to construction of vaccine strainswithNS1 deletions.
IMPORTANCE
Nonstructural protein (NS1) of influenza virus has multiple functions. Besides its role in antagonizing host antiviral activity,
NS1 is also believed to be involved in regulating virus replication, butmechanistic details are not clear. TheNS1 protein is a virulence
determinantwhich inhibits both innate and adaptive immunity and live attenuated viruseswithNS1 deletions showpromise as effec-
tive vaccines.However, deletion ofNS1 causes severe attenuation of virus replication during infection, impeding functional studies and
vaccine development.We characterized a replication-competentDelNS1 viruswhich carries anA14U substitution in the 3=noncoding
region of the vRNAMsegment.We found thatM-A14Umutation supports virus replication throughmodulation of alternative splic-
ing ofmRNAs transcribed from theM segment.Our findings give insight into the role ofNS1 in influenza virus replication andprovide
an approach for constructing replication-competent strainswithNS1 deletions for use in functional and vaccine studies.
Influenza A virus is an important human respiratory tract patho-gen which causes annual epidemics and occasional pandemics
(1, 2). The influenza A virus genome contains eight negative-sense
single-strandedRNA segments (3). The segmented genome allows
frequent reassortment events to occur between different influenza
viruses, which can lead to altered pathogenic and transmission
properties in reassortant viruses (1, 4). The influenza A virus rep-
lication process is regulated by host and viral factors during the
infection cycle (5, 6). Entry of influenza virus into cells is initiated
by attachment of viral hemagglutinin (HA) to cellular sialic acid
receptors, which mediates an endocytotic process to release the
viral genome into the cytoplasm. The viral genome is subse-
quently imported into the nucleus via an importin-/importin-
1-dependent nuclear import pathway, where the influenza virus
utilizes genome-bound viral RNP polymerase complex and host
transcriptionmachinery to replicate the viral genome and express
viral mRNA for protein synthesis (6). At least 14 viral proteins
have been identified from virus-infected cells to date (3, 7–11).
Among these viral proteins, PB1, PB2, PA, NP, HA, NA, M1, M2,
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NS1, and NS2 (NEP) are regularly expressed in infected cells. Ex-
pression of PB1-F2, PB1-N40, and PA-X is less consistently ob-
served and may be associated with viral strain and infection con-
ditions (9–12). Expression of an M2-related protein, M42, was
also reported during infection with virus mutated at the mRNA4
splice donor site in the M segment transcript (7). However, one
study reported thatmany influenza A virionsmay fail to express at
least one essential viral protein and become replication-incompe-
tent infectious particles (13). Expression of viral proteins is subject
to both viral and host controls. It is believed that differential reg-
ulation of viral protein expression results in differences in the
replication efficiency of virus, leading to variable pathogenic out-
comes of infection.
Among the eight genome segments of influenza A virus, both
the NS and M segments express differentially spliced transcripts.
Two matured mRNAs, NS1 and NS2 (NEP), and four mRNAs,
M1,M2,M3, andM4, are expressed from theNS andM segments,
respectively (3). While there are four differentially spliced tran-
scripts from theM segment, only thematrix (M1) and ion channel
(M2) proteins have known roles in influenzaA virus infection.M1
and M2 have essential functions in viral nuclear export, virion
packaging, and budding during virus replication (14–16). No
known function has been found for the other twomRNAs derived
from the M segment, mRNA3 and mRNA4. A study of viral
mRNA kinetics found that accumulation of M1 andM2mRNA is
regulated during virus infection of cells (17). A similar phenome-
non is also observed in NS1 and NS2 (NEP) splicing regulation,
which is coordinated with the progress of virus infection (18). It is
important to understand how these differentially spliced forms of
mRNAs are regulated in influenza virus infection. A study by Shih
et al. reported that the viral polymerase complex regulates the
utilization of alternative 5= splice sites in influenza virus M1
mRNA, in coordination with the cellular splicing factor SF2/ASF,
to control the expression of M2 mRNA during virus replication
(19, 20). However, another study showed that the NS1 protein
regulates splicing of M segment mRNAs and that this activity re-
quires NS1 to possess RNA binding function (21). Adaptive sub-
stitutions were reported to be gained in the M segment through
passage of a reassortant virus containing H5 and N1 from A/tur-
key/Turkey/1/05 and the remaining segments from the A/PR/8/34
strain, but with NS1 deleted (22). While the specific functions of
these M segment substitutions were not characterized, the studies
seem to suggest that there is an interaction between NS1 and M
functions in virus replication (21, 22).
Although the NS1 protein is not essential for viral replication,
it has multiple functions, and deletion of the NS1 gene leads to
severe attenuation of influenza virus replication (23). Numerous
studies on the biology of NS1 have focused on its functions in
antagonism of host antiviral activity (24). It is believed that the
attenuation of DelNS1 virus may be due to a loss of ability to
inhibit host expression of interferon (IFN), since virus without
NS1 is able to replicate normally in interferon-deficient cells (25,
26). However, several studies have shown that NS1 may also be
involved in regulation of influenza virus transcription and repli-
cation through other mechanisms (27, 28). To delineate the
mechanism of NS1 protein function in regulation of virus repli-
cation, we employed a system where we created DelNS1 influenza
viruses derived from the A/WSN/33 and A/PR/8/34 strains.While
deletion of the NS1 gene usually led to severe attenuation of vi-
ruses in interferon-competent systems, we discovered that an
adaptive substitution, A14U, in the 3= noncoding region (NCR) of
the M segment of viral RNA (vRNA) significantly enhances the
replication of DelNS1 viruses. Further characterization revealed
that DelNS1 viruses are unable to express sufficient amounts of
M2mRNA, probably due to the absence of NS1 function, and that
the M-A14U substitution restores M2 expression.
MATERIALS AND METHODS
Cells and viruses. Human embryonic kidney (HEK) 293T (ATCC) and
Vero cells (ATCC) were cultured at 37°C in Dulbecco’s minimal essential
medium (DMEM) supplemented with 10% fetal bovine serum, 100
units/ml penicillin, and 100 g/ml streptomycin sulfate (Life Technolo-
gies), while MDCK (ATCC) cells were grown in Eagle’s minimal essential
medium (MEM) supplemented with the same amounts of serum and
antibiotics. All influenza A viruses used in this study were rescued by
reverse genetics and amplified inMDCK cells, as described previously (28,
29). Viruses were purified using Amicon Ultra-15 centrifugal filter units
(100KD) (Millipore) to remove the cytokines in themedium. Sendai virus
(SeV) was propagated in embryonated chicken eggs.
Plasmid construction. TheNS1 deletion plasmid was constructed ac-
cording to the protocol described in a previous report (25). In brief, in-
verse PCRwas carried out to delete the intron of the NS gene inserted into
the pHW2000 vector (a kind gift provided by Robert Webster of St. Jude
Children’s ResearchHospital, USA), and the plasmidwas phosphorylated
and self-ligated (29, 30). Primers for inverse PCR were 5=-GACATACTG
ATGAGGATGTCAAAAATG-3= (NS-529F) and 5=-CTGAAAGCTTGAC
ACAGTGTTTGG-3= (NS-56R). For point mutations, the QuikChange II
site-directed mutagenesis kit (Stratagene) was used.
Passage of the DelNS1 virus. Blind serial passage of the DelNS1 virus
was performed in this study. The DelNS1 virus was first rescued by
cotransfecting eight pHW2000 plasmids containing the eight segments of
the influenza virus genome into a HEK293T/MDCK mixed cell culture;
the supernatant was subsequently collected at 72 h posttransfection and
designated passage 0 (P0) virus. The P0 virus obtained from the rescue
procedure was used to infect MDCK cells in a T25 flask at 37°C. Two or
three days later, the supernatant was transferred to infect fresh MDCK
cells. Virus titers were measured at each passage. After 5 passages, when
the virus titer in the subculture had stabilized, a full genome sequence of
each of the DelNS1 virus passages was obtained and analyzed.
Reporter assay. Dual luciferase reporter assays were carried out as
previously described (29). HEK293T cells were seeded onto 48-well plates
and cotransfected with 50 ng each of the tested plasmids and firefly lucif-
erase reporter containing noncoding regions from the M segment (29),
together with 10 ng Renilla luciferase reporter as a control. After 24 h of
culture, luciferase activity was measured according to the instructions of
the manufacturer (Promega). For the IFN- promoter activity reporter
assay, cells were infected with the indicated viruses at a multiplicity of
infection (MOI) of 1 (influenza A virus) or 50 HA units (Sendai virus) at
24 h posttransfection. All firefly luciferase values were normalized using
the Renilla luciferase values.
Growth kinetics. MDCK or Vero cells at 80 to 100% confluence
seeded in 24-well plates were infectedwith the indicated viruses at anMOI
of 0.1. After absorption for 1 h, the supernatant was removed and cells
washed twice with 500 l phosphate-buffered saline (PBS). Infected cells
were overlaid with MEM containing 1 g/ml tosylsulfonyl phenylalanyl
chloromethyl ketone (TPCK)-treated trypsin (Sigma) and incubated at
37°C. Supernatants were collected at the indicated time points and the
virus titer determined by plaque assay in MDCK cells.
Plaque assay. Tenfold serial dilutions of each virus to be tested were
made in MEM. Confluent MDCK cells seeded onto 6-well plates were
inoculated with virus for adsorption at 37°C for 1 h before supernatant
was removed. Cells were washed twice with PBS and then overlaid with
1% MEM agarose containing 1 g/ml TPCK-treated trypsin. Plates were
placed upside down in a 37°C incubator for 48 h. Plates were then fixed
with 25% formalin for at least 2 h at room temperature. After stainingwith
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1% crystal violet in 20% ethanol, plates were washed with tap water to
remove excess dye. Plaques were visualized with the naked eye and
counted. In our hands, the plaque assay detects influenza virus at concen-
trations of1 PFU/ml.
Western blotting. Western blotting of influenza virus proteins was
performed as previously described (27). Briefly,MDCKcells were infected
with the indicated viruses at anMOI of 5 and lysed at different time points
with cell lysis buffer (50 mM Tris-HCl, 150 mM NaCl, and 1% Triton
X-100, pH 7.4). Cell debris was discarded after centrifugation at a speed of
12,000  g for 15 min. Native polyacrylamide gel electrophoresis (N-
PAGE) was performed as follows. Briefly, a 7 to 8% polyacrylamide gel
was made without the addition of SDS and with the stacking gel omitted.
Samples for N-PAGE were lysed with the passive lysis buffer used in the
luciferase assay, as previously described (29). After mixing with 5 load-
ing buffer (1MTris-HCl [pH 6.8], 50% glycerol, 1% bromophenol blue),
samples were either stored at80°C or analyzed immediately, with the gel
being prerun for 30 min at a constant current of 40 mA at 4°C before
loading samples. Gels were then processed in a manner similar to that for
SDS-PAGE. Mouse monoclonal anti-M1 (sc-57881) and rabbit poly-
clonal anti-IRF3 (sc-9082) antibodies were purchased from Santa Cruz
Biotechnology. Mouse monoclonal anti-M2 (ab5416) was purchased
from Abcam. Mouse monoclonal anti--tubulin was purchased from
Sigma. NP,HA, andNS1were detected using laboratory-made antibodies
at dilutions of 1:5,000, 1:3,000, and 1:5,000, respectively.
qRT-PCR.Quantitative real-time PCR (qRT-PCR) was performed as
previously described (29). At the indicated time points after infection or
transfection, total RNA was isolated using RNAiso (TaKaRa). DNA con-
tamination was removed by DNase (Ambion) treatment. Approximately
200 ng total RNA was reverse transcribed using a high-capacity cDNA
reverse transcription kit (Life Technologies). The Uni12 and oligo(dT)
primers were used for preparing mRNA and vRNA, respectively, in re-
verse transcription reactions. The SYBR Premix Ex Taq kit (TaKaRa) was
used for real-time PCR. Primers for WSN-M1 were 5=-CGGTCTCATAG
GCAAATGGT-3= (M-478F) and 5=-CAATATCCATGGCCTCTGCT-3=
(M-616R). Primers for WSN-M2 were 5=-CCGAGGTCGAAACGCCTA
TC-3= (WSN-M2-F) and 5=-CTCTGGCACTCCTTCGGTAG-3= (WSN-
M2-R). The forward primer for WSN-mRNA3 was 5=-AGCAAAAGCAG
GCCTATC-3= (WSN-mRNA3-F), and the forward primer for WSN-M4
was 5=-ACCGATCTTGAGGCCTATC-3=. The reverse primer used for
WSN-mRNA3 and WSN-M4 was WSN-M2-R. The forward primer for
PR8-M1 was the same as the WSN-M1 forward primer, M-478F, and the
reverse primer was 5=-CAACCTCCATGGCCTCTGCT-3=. The reverse
primer for PR8-M2 and PR8-mRNA3was 5=-CTTTGGCACTCCTTCCG
TAG-3=, and forward primers were WSN-M2-F and WSN-mRNA3-F,
respectively. Primers for WSN-NP were 5=-GGTGAGAATGGACGGAG
AAC-3= (NP-625F) and 5=-CCGGCTCTCTCTCACTTGAT-3= (NP-
738R). Primers for canine IFN-were 5=-CCAGTTCCAGAAGGAGGAC
A-3= (forward) and 5=-CCTGTTGTCCCAGGTGAAGT-3= (reverse).
Primers for canine -actin were 5=-CCCAAGGCCAACCGCGAGAAGA
T-3= (forward) and 5=-GTCCCGGCCAGCCAGGTCCAG-3= (reverse).
The relative mRNA levels were analyzed using an established protocol
(31). The amplification specificity of qRT-PCRwas confirmed bymelting
curve analysis at the end of each program.
Mouse infection. Mouse experiments were performed using 6- to 8
week old female BALB/c mice as described previously (29). To determine
viral replication in lung tissues, groups of 3micewere infected intranasally
with 1 104 PFU ofWSN-WT,WSN-DelNS1-M-WT, orWSN-DelNS1-
M-A14U virus, diluted in 25l of PBS. Three days later, mice were eutha-
nized and the lungs removed for homogenization in 1 ml PBS. Viral titers
were then determined by plaque assay in MDCK cells. To determine the
pathogenicity of the viruses, groups of 6mice were inoculated intranasally
with 5 104 PFU of wild-type (WT) orDelNS1-M-A14U virus in 25l of
PBSorwith PBS alone, and the bodyweights of infected and control group
mice were recorded daily for 14 days. Mice with body weight losses of
greater than 25% of the initial body weight were euthanized, in accor-
dance with animal ethics guidelines. The protocols used in this experi-
ment were approved by the Committee on the Use of Live Animals in
Teaching & Research (CULATR-3064-13), University of Hong Kong.
RESULTS
TheA14Umutation in theM segment is sufficient to restore the
growth of DelNS1 WSN virus. Although the NS1 protein of in-
fluenza virus is not essential for virus replication, viruses that do
not express functional NS1 are severely attenuated and can repli-
cate only in IFN-deficient systems (25, 32). Helper viruses which
express NS1 in cells have been used to support production of
DelNS1 virus for vaccine studies (33). Substitutions in the M and
NS segments have been shown to restore the growth of DelNS1
virus replication in a study using a reassortant virus containing
HA and NA from an H5N1 virus and internal segments from
A/PR/8/34 (22). However, the mechanism for the restoration of
growth was not defined. To better understand the role of NS1 in
virus replication and to develop a method for making DelNS1
viruses, we made a DelNS1 version of the A/WSN/33 strain (Fig.
1A). Deletion of NS1 was confirmed by examination of the viral
genome, and plaque analysis showed DelNS1 viruses to form sig-
nificantly smaller plaques thanwild-type virus (Fig. 1B andC).We
found that the replicative ability of the WSN-DelNS1 virus in-
creased within three passages in MDCK cells, with the virus titer
rising almost 2 logs compared to that of the original DelNS1 virus
(P1) (Fig. 1D). Sequence analysis confirmed that a variant virus
had been generated but found only one substitution, A14U, in the
3=noncoding region of the vRNAMsegment (M-A14U); no other
mutations were found elsewhere in the genome (Fig. 1E). To con-
firm that introduction of M-A14U in the M segment is not a ran-
dom event, the experiment was repeated and the same A14U vari-
ant obtained. To further test if the M-A14Umutation is sufficient
to increase the growth of DelNS1 virus, we compared efficiencies
of WSN-DelNS1 viruses with M-WT or the M-A14U, M-A14U-
CM15, M-A14G, or M-A14C mutation rescued using reverse ge-
netics and then plaque titrated the rescued viruses inMDCK cells.
A14G is biochemically similar to A14U, and the corresponding
virus was also rescued, but not those with the A14Cmutation. To
test potential disruption of base pairing by A14U, as it has been
observed that mutations at positions 12 and 13 can affect virus
growth (34), an M-A14U-CM15 mutant which contains an addi-
tional complementary mutation at position 15 at the 3= end of M
cRNA was included. It appears that the A14U substitution is
unique and requires no complementary mutation. The titer of
rescued DelNS1-M-A14U mutant viruses was as high as 1.75 
105 PFU/ml, about 750-fold higher than that of the M-WT
DelNS1 virus (Fig. 1F). To test if the A14U substitution may also
arise in other cells, we passaged WSN-DelNS1 virus in Vero cells.
However, no mutation was observed after more than eight pas-
sages. To further verify that M-A14U also supports replication of
other influenza virus strains, we introduced this substitution into
the M segment of a DelNS1 version of the A/PR/8/34 strain and,
consistent with the observation with WSN, found that M-A14U
significantly enhances the titer of virus rescued (Fig. 1G), while
PR8-DelNS1 virus without theM-A14U substitution could not be
rescued. These results indicate that the M-14U substitution can
restore virus replication in the absence of NS1 protein expression.
The M-A14U substitution supports virus replication but
does not suppress IFN expression. Previous studies showed that
DelNS1 influenza virus is unable to replicate in MDCK cells and
A14U in M Segment Supports NS1 Deletion Virus Growth











can be grown only in Vero cells (26, 35). Analysis of growth kinet-
ics showed thatM-A14UDelNS1 virus is able to replicate to a titer
comparable to that of the wild-type virus (less than one log lower)
in both MDCK and Vero cells (Fig. 2A and B). Similarly, the
M-A14U substitution supports PR8 DelNS1 virus replication in
Vero and MDCK cells, while PR8 DelNS1 virus without this sub-
stitution cannot be propagated (Fig. 2C and data not shown). The
function of the NS1 protein as a viral antagonist of host antiviral
activity is well defined (24). As expected, deletion of NS1 attenu-
ates virus ability to suppress interferon expression, asmeasured in
a reporter assay and by qRT-PCR of IFN- activation (Fig. 3A and
B). The DelNS1-M-A14U virus is unable to suppress activation of
IRF3 in infected cells (Fig. 3C). While M-A14U enables DelNS1
virus to grow more efficiently than WSN-DelNS1-M-WT virus,
this substitution has no effect on suppression of interferon (Fig.
3D). To further determine if the A14U substitution in the M seg-
mentmay alter the pathogenic properties of virus in vivo, we com-
pared the virulence and replication in lung tissues of WSN-WT
and WSN-DelNS1-M-A14U mutant viruses in mice. Our results
show that while wild-type WSN strains cause rapid body weight
FIG1 Construction and establishment of stabilizedWSN-DelNS1 virus. (A) Schematic illustration of theNS segment transcripts and theNSmutantwith anNS1
deletion (DelNS1). TheDelNS1 plasmidwas constructed by deleting the intron region ranging fromnt 57 to 528 in theNS segment. NCR, noncoding region. (B)
Confirmation of NS1 deletion in rescued DelNS1 viruses. Viral RNA was extracted from P1 virus, and the NS segment was amplified by RT-PCR and analyzed
using agarose gel electrophoresis. (C) Plaque sizes of DelNS1 and wild-type A/WSN/33 viruses. (D) Titer (PFU/ml) of DelNS1 virus after each passage. (E)
Sequence analysis of the DelNS1 virus genome revealed an A-to-U substitution at nucleotide position 14 in the M segment noncoding region. The noncoding
region ismarked by a black line, and theA14Umutation is indicatedwith an arrowhead. (F)Comparison of rescue efficiency forWSN-DelNS1 viruses containing
M-WT andM-A14U, M-A14U-CM15, M-A14C, and M-A14G substitutions. NR, not rescued. (G) Rescue efficiency of PR8-DelNS1 viruses containing M-WT
or M-A14U. The DelNS1 viruses were rescued with the indicated M-WT or M mutant plasmids in mixed HEK293T and MDCK cell cultures and then titrated
by plaque assay. Values plotted are means ( standard deviations [SD]) (n 3) and are representative of data from at least 5 independent experiments.
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loss and death in infected mice, no apparent pathogenicity is ob-
served with WSN-DelNS1-M-A14U mutant virus. Estimation of
virus titers in the lung tissues of infected mice shows that both
WSN-DelNS1-M-A14U and WSN-DelNS1-M-WT mutants rep-
licate poorly in lung tissues, to levels approximately 3 logs lower
than are observed for WSN-WT virus (Fig. 3E and F). Taken to-
gether, these results suggest that introduction of theM-A14U sub-
stitution would not change the avirulent properties possessed by
DelNS1 virus that make it suitable for use in vaccine strain devel-
opment.
TheM-A14U substitution affects splicing ofM transcripts in
virus replication.TheNS1 protein is not a component of the viral
polymerase complex. The observation that a sole A14U substitu-
tion in the M segment restores replication in DelNS1 virus sug-
gests that NS1 may be involved in regulating replication or tran-
scription from the vRNA M segment. To understand the
molecular basis for the role of the M-A14U substitution in sup-
porting replication of viruswith anNS1deletion, we examined the
expression of virus proteins during infection of MDCK cells with
DelNS1-M-A14U virus. While the expression pattern of viral HA
and NP proteins is largely similar in WSN-WT and DelNS1-M-
A14U virus infections (Fig. 4A), we found thatM2 expression was
unchanged but that M1 levels were significantly decreased in
M-A14U DelNS1 compared to WSN-WT virus infections. Com-
parison of viral protein expression betweenDelNS1-M-A14U and
DelNS1-M-WT viruses also showed that the A14U substitution
had an effect on the M1 and M2 proteins but not on HA and NP
(Fig. 4B). However, the enhancement effect of the M-A14U sub-
stitution on M2 protein expression is not apparent in WSN virus
with intact NS1 function (Fig. 4C), suggesting that M-A14U may
be essential for compensation of the loss of NS1 functions in reg-
ulation of expression and splicing of M mRNAs.
The M-A14U mutation elevates expression of M2 mRNA
through downregulation of mRNA3 during virus replication.
During M segment transcription, differential splicing occurs to
generate four transcripts, with M1 and M2 mRNAs expressing
matrix (M1) and viral ion channel (M2) proteins, respectively,
during influenza virus infection (Fig. 5A). The function of
mRNA3 andmRNA4 is unknown. Notably, the A14Umutation is
located in the mRNA3 splicing consensus sequence, which covers
nucleotides (nt) 9 to 17 at the 5= end of the noncoding region ofM
mRNAs.We predict that the A14U substitution alters the splicing
donor (SD) site consensus sequence of mRNA3 from CAG/GUA
to CAG/GUU and affects production of mRNA3. It seems likely
that the A14U substitution in the vRNA M segment supports
DelNS1 virus growth by downregulating mRNA3 expression to
increase the ratio of M2 to M1 mRNA expression. To verify this
hypothesis, we used qRT-PCR analysis to examine mRNA3 levels
in virus-infected cells. As expected, among the four M mRNA
transcripts, M1, M2, and M4 were significantly increased but
mRNA3 was almost completely abolished in WSN-DelNS1-M-
A14Uvirus-infectedMDCKcells (Fig. 5B). In contrast, expression
ofNPmRNAwas not affected byM-A14U substitution inDelNS1
viruses (Fig. 5B), suggesting that deletion of NS1 is specifically
FIG 2 Growth kinetics of the M-A14U-DelNS1 virus in MDCK and Vero cells. (A and B) Column-purified reverse genetic WSN-WT,WSN-DelNS1-M-A14U,
and WSN-DelNS1-M-WT viruses were used to infect MDCK cells (A) or Vero cells (B) at a multiplicity of infection (MOI) of 0.1. Supernatants were collected
at the indicated time points and virus titrated by plaque assay. (C) Column-purified reverse genetic PR8-WT and PR8-DelNS1-M-A14U viruses were used to
infect MDCK cells (left panel) and Vero cells (right panel) at an MOI of 0.1. Supernatants were collected at 24 h postinfection and titrated by plaque assay. The
values (mean SD; n 3) plotted are representative data from at least 3 independent experiments.
A14U in M Segment Supports NS1 Deletion Virus Growth











FIG 3 Loss of IFN- suppression activity in WSN-DelNS1 viruses. (A) HEK293T cells were transfected with an IFN- reporter plasmid 24 h prior to infection
with eitherWSN-WT orWSN-DelNS1-M-A14U at anMOI of 1 or with the positive control, Sendai virus (SeV), at 50 HA units. After 24 h, cells were harvested
and cell lysates prepared for estimation of luciferase activity. The luciferase assays were performed in triplicate, and values were normalized to the Renilla
luciferase control. (B) IFN- and viral NP mRNA levels were quantified by qRT-PCR after MDCK cells were infected with WSN-WT or WSN-DelNS1-
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associated with regulation of expression from the M segment. To
further prove that M-A14U affects differential splicing from M1
mRNA, HEK293T cells were transfected with either M-A14U or
M-WT segment plasmids which express full-length M mRNA.
While levels of M1 mRNA are similar for M-WT and M-A14U
plasmids, expression of mRNA3 is markedly downregulated and
that of M2 mRNA is significantly upregulated from the M-A14U
plasmid (Fig. 5C). Coexpression of NS1 further demonstrated the
positive effect of NS1 on transcription of M mRNAs; the A14U
substitution may have arisen in the DelNS1 virus to compensate
for the NS1-associated enhancement of MmRNA expression.We
showed above that theM-A14U substitution has a similar effect in
supporting replication of DelNS1 virus derived from the A/PR/
8/34 strain (Fig. 1G and 2C). Examination of differentially spliced
M transcripts from PR8-DelNS1-M-A14U virus-infected cells
found patterns similar to those observed with WSN-DelNS1-M-
A14U (Fig. 5D), supporting conservation of function for this nu-
cleotide in both WSN and PR8 strains. Collectively, these results
clearly show that M-A14U substitution in the vRNA M segment
alters the splicing pattern of M1 mRNA during virus infection,
even in the absence of other viral proteins.
The M-A14U mutation results in an increased ratio of M2
mRNA to M1 mRNA. To further explore the molecular mecha-
nism underlying the effect of M-A14U on virus replication in the
absence ofNS1 expression, wemademutants which downregulate
expression of mRNA3. The M-G12C-CM13 mutant virus was re-
ported to markedly downregulate the expression of mRNA3 (34).
We confirmed that expression of mRNA3 is reduced in WSN-M-
A14U, WSN-M-A14G, and WSN-MG12C-CM13 virus infection
(Fig. 6A). However, growth kinetics analysis showed that replica-
tion of this virus is attenuated, with the WSN-DelNS1-M-G12C-
CM13 virus unable to be efficiently rescued (Fig. 6B), suggesting
that downregulation of mRNA3 may not be directly associated
with virus growth. The M1 matrix protein is involved in vRNA
nuclear export, while M2 has an ion channel function and is in-
volved in the virus uncoating and budding process during influ-
enza virus replication. It is possible that there is coordination of
expression of M1 and M2 over the course of the viral replication
process through regulation of alternative splicing of M1 mRNA
and that NS1 may play a role in this. It seems that the ratio of M1
to M2 is altered in DelNS1 virus infection, as seen in the above
results (Fig. 4 and 5). M2 is reported to be selectively expressed
during the early hours of virus infection (21), whichmay suggest a
critical role for M2 in the early phase of virus replication. Besides
its role in the virus uncoating and budding process,M2 is reported
to interact with autophagosomes and inflammasomes (36, 37),
suggesting that it may play other roles during virus replication. It
is possible that in the absence of NS1, which has multiple func-
tions to antagonize host antiviral activities, DelNS1 viruses may
adapt to preferentially express M2 in an attempt to maintain an
optimal balance for virus replication. To understand the effect of
M-A14Uon regulation of differential splicing ofM transcripts, the
ratio ofM2mRNA toM1mRNA in virus-infected cells was deter-
mined. For this purpose, we compared the M2/M1 ratios in cells
infected with WSN-M-A14U, WSN-DelNS1-M-WT, WSN-
DelNS1-M-A14U, and WTWSN virus. The M2/M1 splicing effi-
ciency in WSN-DelNS1-M-A14U-infected cells was about 6-fold
higher than that in WSN-DelNS1-M-WT-infected cells (Fig. 6C).
However, comparison between WSN-WT and WSN-M-A14U
M2/M1 ratios revealed that while M2 is upregulated with the
A14U substitution, the effect is not as significant (less than a 2-fold
difference) as that seen between the WSN-DelNS1 viruses (Fig.
6C). As expected, expression of mRNA3 is diminished and M4
M-A14U at an MOI of 0.1 and cultured for 16 h. Values were normalized against canine actin. (C) Suppression of IRF3 dimerization in HEK293T cells infected
withWSN-WT,WSN-DelNS1-M-A14U, or Sendai virus was analyzed by native gel electrophoresis. (D) Activity in suppressing IFN- expression was compared
inMDCK cells infected withWSN-DelNS1-M-WT orWSN-DelNS1-M-A14U virus. Similar to the experiment described for panel B, MDCK cells were infected
with the indicated viruses at an MOI of 0.1, and at 16 h postinfection, IFN- and NP mRNA levels were quantified by qPCR. Values were normalized to canine
actin. (E) Groups of six BALB/c mice, aged 6 to 8 weeks, were intranasally inoculated with 5 104 PFU of WSN-WT or WSN-DelNS1-M-A14U mutant virus,
and body weight was monitored daily for 14 days postinfection. (F) Replication efficiency of viruses in lung tissues of infected mice. Groups of three mice were
infected with 104 PFU of WSN-WT, WSN-DelNS1-M-WT, or WSN-DelNS1-M-A14U mutant viruses and then euthanized at 72 h postinfection, with lung
tissues from eachmouse being collected and homogenized for virus titration by plaque assay usingMDCK cells. Statistical significance was analyzed by one-way
analysis of variance (ANOVA) or Student’s t test (**, P	 0.01). The bars plotted showmeans SD (n 3), and the results represent at least three independent
experiments.
FIG 4 Effect of M-A14U mutation on M1 and M2 protein expression. (A)
MDCK cells were infected with WSN-WT or WSN-DelNS1-M-A14U virus at
an MOI of 2. Cells were harvested at the indicated time points and cell lysates
analyzed by Western blotting with specific antibodies, as described in Materi-
als andMethods. (B)MDCK cells were infected withWSN-DelNS1-M-WT or
WSN-DelNS1-M-A14U virus at an MOI of 0.1. At 16 h postinfection, cell
lysates were collected forWestern blottingwith specific antibodies. (C)MDCK
cells were infected withWSN-WT orWSN-M-A14U virus at anMOI of 5. Cell
lysates were prepared at the indicated time points for Western blotting with
specific antibodies. -Tubulin was included as a loading control. All of the
results are representative of three independent experiments.
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FIG 5 Effect of M-A14U substitution on alternative splicing of M transcripts. (A) Schematic illustration of the M segment transcripts. The sequence of the 3=
noncoding region of the vRNAM segment is shown in red, with themRNA3 splicing donor (SD) site highlighted in yellow. Splicing consensus sequences for the
donor site are indicated in green above the noncoding region sequence (M, A or C; R, A or G). (B) Analysis of levels of differentMmRNAs in virus-infected cells.
MDCK cells were infected with the indicated viruses at anMOI of 0.1. Total RNAwas isolated at 16 h postinfection. ThemRNA levels forM1,M2, mRNA3, and
M4 were determined by quantitative RT-PCR, as described in Materials and Methods. (C) HEK293T cells were transfected with pHW2000-WSN-M-WT or
pHW2000-WSN-M-A14U plasmid with or without cotransfection of pCX-WSN-NS1 for coexpression of NS1. At 48 h posttransfection, total RNAs were
isolated. After DNase treatment, the mRNA levels were determined by quantitative RT-PCR. (D) MDCK cells were infected with PR8-WT, PR8-M-A14U, or
PR8-DelNS1-M-A14U virus at an MOI of 0.1. At 16 h postinfection, total RNAs were isolated and mRNA levels measured by qPCR. M2/M1 mRNA and
mRNA3/M1 mRNA ratios are shown. All the results plotted indicate means SD (n 3) and are representative of three independent experiments.











mRNA is downregulated in both WSN-WT-M-A14U and WSN-
DelNS1-M-A14U virus infections (Fig. 6D and E). To further test
the effect of mRNA3 on virus growth, we expressed mRNA3 from
a plasmid, but we found no negative effect on virus titers (Fig. 6F),
which suggests that alternative splicing for expression of mRNA3
may be solely for modulating the levels of M1 and M2 mRNAs.
These results support the hypothesis thatM-A14Umutation leads
to increased alternative splicing for production of M2, and per-
haps also M1, mRNAs to enhance virus replication in the absence
of NS1 expression.
The M-A14U mutation enhances alternative splicing of M2
mRNAs and synthesis of M vRNA. Previous studies have sug-
gested that splicing of M segment mRNAs can be regulated by the
viral RNP complex, in conjunction with the host factor SF2 (20),
or NS1 (21). Are these mechanisms associated with the M-A14U
substitution? We have presented evidence showing that the
M-A14U substitution affects splicing efficiency of M1mRNA and
that this property is required to compensate for lack of NS1 ex-
pression. In a mechanism where NS1 is involved in the regulation
of splicing of M transcripts into M2 mRNA during virus replica-
FIG 6 Effect of M-A14U substitution on M2/M1 mRNA ratio. (A) MDCK cells were infected with WSN-WT, WSN-M-A14U, WSN-M-A14G, or WSN-M-
G12C-CM13 virus at anMOI of 5. Total RNAswere extracted at the indicated time points and levels ofmRNA3determined by quantitative RT-PCR. (B)Analysis
of growth kinetics of WSN-WT,WSN-M-A14U, WSN-M-A14G, andWSN-M-G12C-CM13 viruses. MDCK cells were infected with these viruses at an MOI of
0.001. Supernatants were collected at the indicated time points and titrated by plaque assay. (C to E)MDCK cells were infected withWSN-WT,WSN-M-A14U,
WSN-DelNS1-M-WT, or WSN-DelNS1-M-A14U virus at an MOI of 0.1. At 16 h after infection, total RNAs were isolated, and the M2/M1, mRNA3/M1, and
M4/M1 mRNA ratios were determined by quantitative RT-PCR. (F) Effect of mRNA3 on virus replication. HEK293T cells were transfected with pCX-WSN-
mRNA3 or a control vector 24 h prior to infection withWSN-DelNS1-M-A14U virus at anMOI of 0.1. Supernatants were collected at the indicated time points
and virus titrated by plaque assay. All of the bars andpoints plotted indicatemeans SD (n 3) from three independent experiments. **,P 0.0013 by Student’s
t test.
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tion, it seems possible that DelNS1 virus may be forced to obtain
an adaptive substitution in the regulatory element at the promoter
region of the vRNA M segment which normally associates with
NS1 in order to compensate for a lack of NS1 function. To test this
hypothesis, we examined the effect of restoringNS1 expression on
the M2/M1 ratio in DelNS1-M-WT virus-infected cells. To this
end, increasing amounts of NS1 expression vector were trans-
fected into HEK293T cells 24 h prior to infection with virus, and
expression of M1 and M2 viral mRNAs was estimated by quanti-
tative RT-PCR. The amount of the M2 spliced form rises as levels
of NS1 expression increase in DelNS1-M-WT virus-infected cells
(Fig. 7A). Using plasmids which express both the vRNA and
mRNA of the M segment, we found that even in the absence of
other viral proteins, all plasmids with substitutions at position 14
FIG 7 Regulation of MmRNA splicing host machinery by viral NS1 and polymerase proteins. (A) HEK293T cells were transfected with increasing amounts of
pCX-WSN-NS1. At 24 h after transfection, cells were infected with WSN-DelNS1-M-WT, WSN-DelNS1-M-A14U, or WSN-WT virus at an MOI of 0.5. Total
RNAs were isolated at 8 h postinfection and M1 mRNA, M2 mRNA, and mRNA3 levels analyzed by quantitative RT-PCR. (B) HEK293T cells were transfected
with WT and various mutants of the M segment cloned into pHW2000 plasmids, which express M vRNA, with or without the pCX-WSN-NS1 plasmid. Cell
lysates were prepared at 48 h posttransfection for Western blotting with specific antibodies. -Tubulin was included as a loading control. (C) Effect of A14U
substitution on M vRNA replication. MDCK cells were infected with WSN-WT, WSN-M-A14U, or WSN-M-A14G virus at an MOI of 5. At 4 and 10 h
postinfection, total RNAs were isolated for qRT-PCR analysis, and relative amounts of vRNA were determined as described above. (D) The A14U substitution
enhancesMvRNA replication.MDCKcells were infectedwithWSN-DelNS1-M-WTorWSN-DelNS1-M-A14Uvirus at anMOIof 0.1. Total RNAswere isolated
at 16 h after infection. M and NP vRNA levels were determined by quantitative RT-PCR, as described above. All bars plotted show means SD (n 3). The
results represent three independent experiments. **, P	 0.01; ***, P 0.0002 (by Student’s t test).
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expressed higher levels of M2 protein, but not M1, than M-WT,
which supports the hypothesis that M-A14U is associated with
upregulation of the M2 spliced form (Fig. 7B). Cotransfection of
NS1 plasmid M significantly enhances expression of M1 from all
of these plasmids, and levels of M2 are upregulated more signifi-
cantly for plasmids which have a substitution at the 14th position
or at the 12th position to downregulate mRNA3 (G12C-CM13)
(34) (Fig. 6A and 7B). This result strongly suggests that NS1 can
function to allow preferential expression of M1 and M2 through
downregulation of the alterative splicing site for mRNA3, while
substitutions at this splicing site allow efficient processing of M1
into the M2 spliced form.
The A14U substitution occurs in the 3= noncoding region of
theM vRNA segment (5= of cRNA or 5=mRNA), which is also the
promoter region for replication of the viral genome. It is possible
that this mutation affects binding of the viral polymerase complex
to enhance vRNA synthesis from theM segment, producingmore
M1 mRNA for splicing into M2 mRNA during virus replication.
We tested the M vRNA synthesis levels in cells infected with mu-
tant viruses containing variations at position 14 but with an intact
NS1 gene. We found that the level of M vRNA produced from the
WSN-M-A14U mutant was approximately 15-fold higher than
that for WSN-WT virus (Fig. 7C). In contrast, relatively lower
levels of M vRNA were observed for the WSN-M-A14G mutant
than forWSN-WTvirus-infected cells (Fig. 7C).We further tested
if elevated production of M vRNA is associated with DelNS1-M-
A14U virus infection. It is notable that levels of M vRNA are sig-
nificantly higher in WSN-DelNS1-M-A14U than in WSN-
DelNS1-M-WT virus infections, while no similar trend is
observed for NP vRNA (Fig. 7D). Collectively, these results
strongly suggest that the M-A14U mutation positively affects M
vRNA synthesis and that this effectmay be required for replication
of NS1-deficient viruses.
DISCUSSION
Influenza virus utilizes the viral polymerase complex and host
machinery to transcribe and replicate the viral genome in the nu-
cleus. Coordination of expression of viral products for switching
from transcription to replication and nuclear export of vRNAs to
the cytoplasm is critical for optimal replication efficiency. The
viral proteinsM1 andNEP (NS2) are involved in nuclear export of
vRNPs, but details of the mechanism remain unclear (38). M2 is a
structural protein and is involved in the virus uncoating process
during the early phase of entry and virion budding in the late stage
of virus infection (14, 15). M1/M2 and NS1/NS2 (NEP) viral pro-
teins are expressed through alternatively splicedmRNAs from the
M andNS segments, respectively.While there is no direct involve-
ment of proteins from the M or NS segment in the viral polymer-
ase complex, it is suggested that virus replication can be regulated
through modulation of alternative splicing of M1/M2 and NS1/
NEP (NS2) mRNAs (39, 40). While influenza virus utilizes viral
polymerases to replicate and a cap-snatching mechanism to tran-
scribe the viral genome, it is believed that the virus is dependent on
host machinery for mRNA splicing (39). Expression of spliced NS
and MmRNAs is highly regulated. NS1 was found to inhibit host
pre-mRNA splicing through interaction with CPSF and may also
have the same effect on viral mRNA (41, 42), but exactly how the
NS andM transcripts are regulated is not completely understood.
Previous studies showed that both viral and host mechanisms are
involved in the regulation of differential splicing of M mRNAs
(19–21). Because M1 and M2 proteins have essential functions
required for different stages of viral infection, such as RNPnuclear
export, virus assembly, and budding processes, control of the tim-
ing of M1 and M2 expression to optimize efficiency of viral ge-
nome replication is critical for virus infection. The 3= noncoding
region (NCR) of the vRNA M segment contains 25 nucleotides
which comprise a promoter for transcription initiation and alter-
native splicing sites for posttranscriptional processing of mRNA
(Fig. 5A). It has been suggested that the viral polymerase complex
binds onto the NCR promoter region to block the splicing site for
expression of mRNA3, leading to the alternative utilization of an-
other splicing site for M2 mRNA (19, 20). Another study found
that it is the NS1 protein which regulates the accumulation of M2
in virus replication (21). However, the regulatory effect of NS1 on
accumulation of M2 was not observed in Vero cells infected with
DelNS1 virus (43). The question remains as to whether the viral
polymerase proteins, NS1, or both regulate the alternative splicing
of M transcripts.
In this study, we explored the role of the NS1 protein in virus
replication by constructing anNS1deletion virus derived from the
A/WSN/33 influenza virus strain. Interestingly, it was found that a
sole A14U substitution in the noncoding region of theM segment
arose in DelNS1 virus after a few passages. The DelNS1-M-A14U
virus was able to replicate to a level approximately similar to that
for the wild-type virus in cells, indicating a functional linkage
between theNS1 protein and the transcription or replication ofM
vRNA. Four mRNAs, M1, M2, mRNA3, and M4, are expressed
fromM vRNA.We demonstrated that the DelNS1-M-A14U virus
expresses elevated levels of M2 spliced from M1 mRNA while
suppressing expression of mRNA3, linking the role of NS1 with
regulation of the alternative splicing ofM transcripts. More direct
evidence for the effect of A14U on alternative splicing of M
mRNAs came from an analysis of expression of M segments con-
tainingA14Uandother substitutions, performed in the absence of
other viral proteins. TheM-A14U segment expresses higher levels
of M2 protein, while the level of M1 is unchanged (Fig. 7B), sug-
gesting the A14U substitution favors M2 production by the host
splicing machinery. How does the A14U substitution cause ex-
pression of M2 to be upregulated? A14U is situated right within
the splice donor site formRNA3 expression (Fig. 5A), and it seems
likely that this substitution abolishes or affects the binding of
splicing factors to this motif, leading to the selection of the adja-
cent splice donor site which produces M2 mRNA instead. This
hypothesis is supported by the evidence that other substitutions at
this site also enhance M2 expression in the absence of other viral
proteins (Fig. 7B). Restoration of NS1 expression by transfecting
cells with an NS1-expressing plasmid prior to virus infection sig-
nificantly increased the M2/M1 mRNA ratio in DelNS1-M-WT
virus-infected cells, confirming thatNS1 is directly involved in the
regulation of M2 mRNA splicing.
TheA14U substitutionmay have dual roles,modulating vRNA
synthesis and mRNA splicing, as levels of M vRNA were signifi-
cantly enhanced in DelNS1-M-A14U virus infections compared
to DelNS1-M-WT infections, while no similar effect was observed
for NP vRNA. Therefore, a compound effect of the A14U substi-
tution in the M vRNA 3= promoter region would result in higher
efficiency of the viral polymerase complex, generatingmore vRNA
for transcription into mRNA, combined with blockage of the
mRNA3 splicing site to allow expression of M2mRNA.While the
NS1 protein is not recognized as an essential element for virus
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replication, it has multiple functions as an antagonist of host an-
tiviral activity. It seems reasonable to suggest that for a virus lack-
ing NS1 to replicate in cells, alternative viral elements to counter
host antiviral activity would be required. TheM2 protein has been
found to interact with inflammasomes and autophagosomes dur-
ing influenza virus infection. It may be speculated that M2 is re-
quired tomaintain optimal replication for virus under conditions
where NS1 is absent and that the A14U adaptive mutant is thus
selected to drive expression of higher levels of M2 for such pur-
poses.
Because the NS1 protein interferes with both innate and adap-
tive immune responses during virus infection and is an influenza
virulence determinant (44–46), DelNS1 virus is regarded as a
promising live attenuated vaccine candidate (47–50). Animal ex-
periments show that live attenuated vaccines lacking NS1 may
induce better immune responses (45, 46). However, deletion of
NS1 severely affects virus replication, and it is difficult to produce
high titers of attenuated virus for vaccine applications. Attempts
have been made to propagate NS1-deficient viruses to high titers
using various strategies (22, 25, 33). The DelNS1 virus was found
to be restricted to being amplified in limited systems, either in an
IFN-deficient system (25, 47) or in an NS1-expressing system (33,
51). We demonstrate here that a single A14U substitution in the
noncoding region of theM segment was sufficient to support rep-
lication of DelNS1 viruses to a level close to that of wild-type virus
in both MDCK and Vero cells. While the effect of the A14U sub-
stitution on DelNS1 virus replication has been confirmed in
A/WSN/33 and A/PR/8/34 strains in this study, verification of the
influence of this substitution in other influenza virus strains and
subtypes is necessary. The mechanism revealed in this study for
supporting the replication of DelNS1 virus provides important
strategic information relevant to future projects aimed at con-
structing DelNS1 versions of other influenza virus strains.
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